Conclusions: In Chinese and Thai opioid-dependent injectors, we found BUP/NX to be effective in reducing opioid withdrawal symptoms and safe during short-term use. ALT increases were observed over 4-week-follow-up, which are consistent with reports from Western populations. Long-term safety and efficacy evaluations are indicated. (Source: International Journal of Drug Policy)
Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058
Previous post: Compensation Effects on Clinical Trial Data Collection in Opioid-Dependent Young Adults.
Next post: The Possible Consequences of Combining Lorazepam and Buprenorphine/Naloxone: A Case Review
